Literature DB >> 6439820

In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells.

R Rubenstein, R I Carp, S M Callahan.   

Abstract

A rat phaeochromocytoma cell line, termed PC12, was used to study scrapie replication. These cells, in response to the addition of nerve growth factor (NGF), exhibit a number of neuronal properties including morphological differentiation, electrophysiological responsiveness, and neurotransmitter synthesis. Cultures were exposed to scrapie brain homogenate (strain 139A), harvested every week for up to 6 weeks, and assayed for scrapie infectivity. Scrapie replication in vitro was monitored by injecting scrapie agent-exposed NGF-treated PC12 cells into mice and measuring time intervals from injection to onset of clinical symptoms. Mouse incubation periods vary inversely with the amount of scrapie infectivity present. Cells harvested at 7 and 14 days after exposure to scrapie agent showed a decrease in the level of infectivity followed by an increase at subsequent time points. The increase in scrapie infectivity from early to late time intervals after agent exposure clearly indicated replication in vitro. A fusion agent was not necessary to establish infection, and the addition of mouse peritoneal macrophages caused a reduction in the yield of infectivity per culture. Examination of cells by phase-contrast microscopy failed to reveal any cytopathology.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439820     DOI: 10.1099/0022-1317-65-12-2191

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

1.  Cultured cell sublines highly susceptible to prion infection.

Authors:  P J Bosque; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Case for an RNA-prion world: a hypothesis based on conformational diversity.

Authors:  Param Priya Singh; Anirban Banerji
Journal:  J Biol Phys       Date:  2011-02-08       Impact factor: 1.365

3.  A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis.

Authors:  H M Schätzl; L Laszlo; D M Holtzman; J Tatzelt; S J DeArmond; R I Weiner; W C Mobley; S B Prusiner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent.

Authors:  Christopher S Greil; Ina M Vorberg; Anne E Ward; Kimberly D Meade-White; David A Harris; Suzette A Priola
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

Review 5.  Bioassays and Inactivation of Prions.

Authors:  Kurt Giles; Amanda L Woerman; David B Berry; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 6.  Replication of prions in differentiated muscle cells.

Authors:  Allen Herbst; Judd M Aiken; Debbie McKenzie
Journal:  Prion       Date:  2014-02-11       Impact factor: 3.931

7.  A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions.

Authors:  P-C Klöhn; L Stoltze; E Flechsig; M Enari; C Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

Review 8.  Scrapie strain infection in vitro induces changes in neuronal cells.

Authors:  R Rubenstein; H Deng; R Race; W Ju; C Scalici; M Papini; A Rubenstein; R Kascsak; R Carp
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

Review 9.  Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis.

Authors:  S A Priola; B Caughey
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

10.  Cultured peripheral neuroglial cells are highly permissive to sheep prion infection.

Authors:  Fabienne Archer; Corinne Bachelin; Olivier Andreoletti; Nathalie Besnard; Gregory Perrot; Christelle Langevin; Annick Le Dur; Didier Vilette; Anne Baron-Van Evercooren; Jean-Luc Vilotte; Hubert Laude
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.